Lv5
952 积分 2021-07-08 加入
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
27天前
已完结
First-line therapies analysis in advanced/metastatic urothelial carcinoma: prognostic insights in ADCs combined therapy with propensity score analysis and RNA-Seq
1个月前
已完结
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities
1个月前
已完结
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
1个月前
已完结
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer
1个月前
已完结
ENO2 drives tumor cell-induced M2 macrophage polarization to promote colorectal cancer liver metastasis
2个月前
已完结
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial
2个月前
已完结
UBC9-mediated SUMOylation of CORO1C drives lung adenocarcinoma progression via Arp2/3-dependent cytoskeletal remodeling
3个月前
已完结
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
3个月前
已完结
Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC
3个月前
已完结
皖公网安备34019202002308
